AMX three-lens brief
Evidence-based stock research on AMX. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
Outperforming SPY by 22.1pp over 30 days. · RSI at 71 — technically overbought.
- RSI at 71 — technically overbought.
- Outperforming SPY by 22.1pp over 30 days.
AMX closed at $25.80 (+0.16%) as of 2026-11-12. Market cap: $77.02B. P/E (trailing) 15.0. Price is above the 50-day MA and above the 200-day MA. Positives: outperforming SPY by 22.1pp over 30 days.. Concerns: rSI at 71 — technically overbought.. Last quarter: Revenue $250.63B, net income $24.28B, free cash flow $166.89B.
Why three lenses on AMX, not one.
A single reasoning model has blind spots it doesn’t know about. We examine AMX across Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://www.clearpathinvest.app/embed/AMX" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath AMX brief"></iframe>